62,063 Shares of iShares U.S. Pharmaceuticals ETF $IHE Acquired by Virtue Capital Management LLC

Virtue Capital Management LLC purchased a new stake in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) in the third quarter, Holdings Channel.com reports. The firm purchased 62,063 shares of the company’s stock, valued at approximately $6,239,000. iShares U.S. Pharmaceuticals ETF accounts for about 0.8% of Virtue Capital Management LLC’s investment portfolio, making the stock its 27th largest holding.

A number of other hedge funds have also recently bought and sold shares of IHE. Aviance Capital Partners LLC purchased a new stake in iShares U.S. Pharmaceuticals ETF during the 3rd quarter worth approximately $242,000. Raleigh Capital Management Inc. boosted its stake in shares of iShares U.S. Pharmaceuticals ETF by 1,723.4% during the 3rd quarter. Raleigh Capital Management Inc. now owns 7,093 shares of the company’s stock valued at $713,000 after buying an additional 6,704 shares during the last quarter. D.A. Davidson & CO. purchased a new position in shares of iShares U.S. Pharmaceuticals ETF during the 3rd quarter valued at approximately $1,974,000. VestGen Advisors LLC acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF during the third quarter worth approximately $3,746,000. Finally, Lynx Investment Advisory grew its position in shares of iShares U.S. Pharmaceuticals ETF by 10.5% during the third quarter. Lynx Investment Advisory now owns 8,092 shares of the company’s stock worth $813,000 after buying an additional 770 shares in the last quarter.

iShares U.S. Pharmaceuticals ETF Stock Performance

Shares of NYSEARCA:IHE opened at $107.61 on Monday. The company has a fifty day simple moving average of $102.41 and a 200 day simple moving average of $94.74. The firm has a market cap of $1.61 billion, a PE ratio of 17.75 and a beta of 0.47. iShares U.S. Pharmaceuticals ETF has a 12-month low of $74.93 and a 12-month high of $109.43.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.